If your shop vac loses suction fast or clogs constantly, a cyclone separator is one of the best upgrades you can add to your ...
GSK ( GSK) shares clocked seven straight sessions of gains, as the stock rose 1.7% at $60.19 on Friday. The multinational healthcare giant gained 16.8% in the preceding six sessions. The stock has ...
Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...
Zacks Investment Research on MSN
GSK gets EU approval for expanded use of Nucala in COPD
GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...
Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like arthritis, IBD, allergies, and more.
GSK (GSK) stock is in focus as the company wins EU approval to expand its Nucala asthma drug into chronic obstructive ...
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
GBP: higher at USD1.3566 (USD1.3536 at previous London equities close) ...
An infection with Epstein-Barr virus is a nonevent for most people. But for a subset, the virus can contribute to chronic ...
Baltimore residents showed up to city hall furious about unsafe living conditions and abusive building management.
SAN FRANCISCO and BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim ...
Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results